ArticleEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2026
What is the minimum effective wearing dosage of orthotic intervention in adolescent idiopathic scoliosis?
Article in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to estimate the minimum effective orthosis-wearing time (MEWT) needed to prevent curve progression and reduce surgical risk in adolescent idiopathic scoliosis (AIS).
methodsThis retrospective study analyzed 281 patients with AIS who completed orthotic treatment. Compliance was measured using both objective temperature sensors and subjective self-reports, categorized into four daily wear-time levels: 0 to 6, 6 to 12, 12 to 18, and 18 to 24 h. Treatment outcomes at endpoint were classified as improvement (> 5° decrease), stabilization (± 5°), deterioration (> 5° increase), or surgical deterioration (Cobb angle > 50° or requiring surgery). Associations between compliance and outcomes were examined, and MEWT thresholds were estimated within risk-stratified subgroups based on baseline clinical risk factors.
resultsPatients wearing orthoses for 0 to 6 and 6 to 12 h/day showed significantly lower improvement rates and higher deterioration rates than those in the 12 to 18 and 18 to 24 h/day groups. No significant differences in treatment outcomes were observed between the 12 to 18 and 18 to 24 h/day groups, nor between the 0 to 6 and 6 to 12 h/day groups. Risk-stratified logistic regression models showed that MEWT estimates for curve deterioration ranged from 9.3 to 21.6 h/day, depending on target risk (20% to 5%) and Risser sign. For surgical deterioration, MEWT estimates at the 5% target risk ranged from 8.1 to 20.6 h/day. However, for patients with Risser 0 and a baseline Cobb angle > 30°, the model-derived MEWT estimates for target risks of 2% or lower exceeded 24 h/day and were therefore considered clinically infeasible.
conclusionsAlthough orthosis wear of 12 h per day or more was associated with better outcomes in group-level comparisons, MEWT is not uniform and varies by baseline clinical risk factors. Integrating objective compliance monitoring with risk-adapted targets may support personalized orthotic prescriptions, facilitate shared decision-making, and optimize treatment effectiveness.
Indexed as
Identifiers
42570106What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.